In non-tumor tissues, the expression levels of some checkpoints, such as CD28, OX40, CD27, HVEM, CTLA4, PD1, B7-1, TIM3, VISTA, TIGIT, LAYN and CD39 were higher in advanced-stage HCC (Figure 4J). This evidence concerns the gene HAVCR2 and hepatocellular carcinoma.